(MENAFN- Trend News Agency)
The European Union is set to invest 890 million euros (940
million U.S. dollars) in vaccine and drug production in Latin
America and Caribbean countries, European Commission chief Ursula
von der Leyen said on Wednesday, Trend reports citing Xinhua .
In a joint statement with Spanish Prime Minister Pedro Sanchez,
von der Leyen said the new partnership will involve sharing
knowledge and technologies, as well as the creation of a robust
regulatory environment.
The move should boost Latin America's manufacturing capacity,
foster equitable access to safe, effective and affordable health
products, and help strengthen health resilience in the region to
tackle endemic and emerging diseases, said the Commission.
From the autumn, events will be organized to foster
collaborations between the EU's private sector and businesses in
Latin America.
The partnership will also help universities, research centers
and scientists to work together, under the research and innovation
program Horizon Europe.
The partnership follows a similar initiative which was launched
last year on manufacturing and access to vaccines, medicines and
health technologies in Africa. The 1 billion euro initiative was
announced by von der Leyen at the G20 summit in Rome.
MENAFN22062022000187011040ID1104417919
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.